ABBOTT INDIA LTD.

NSE : ABBOTINDIABSE : 500488ISIN CODE : INE358A01014Industry : Pharmaceuticals & DrugsHouse : Abbott India - MNC
BSE8127.9523.35 (+0.29 %)
PREV CLOSE ( ) 8104.60
OPEN PRICE ( ) 8070.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 407
TODAY'S LOW / HIGH ( )8060.00 8146.80
52 WK LOW / HIGH ( )4070.35 8834.05
NSE8102.75-33.95 (-0.42 %)
PREV CLOSE( ) 8136.70
OPEN PRICE ( ) 8100.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 10356
TODAY'S LOW / HIGH( ) 8055.15 8150.05
52 WK LOW / HIGH ( )4100 8820.05
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 22-08 1944
Management Info
Munir Shaikh - Chairman Ambati Venu - Managing Director
Registered Office

Address Unit No. 3,Corporate Park,Sion Trombay Road,
Mumbai,
Maharashtra-400071

Phone 022- 67978888

Email investor.relations@abbott.co.in & webmaster@abbott.co.in

Website www.abbott.co.in

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
03Sep Abbott India planning to bring new pro
Abbott India is reportedly planning to launch new products in the toddle..
27Aug SAIL, Abbott India and Tata Motors to
India’s largest steel maker SAIL has started process to exit some of its..
27Aug Abbott India eyeing to launch 100 prod
Abbott India is eyeing to launch around 100 products over the next five..
27Aug Abbott India spurts on eyeing to launc
Abbott India is currently trading at Rs. 7750.00, up by 149.50 points or..
19Jul Abbott India informs about AGM
Pursuant to Regulation 44 of the Securities and Exchange Board of India..
Financials
Rs. in Millions
QTR Jun 18 ANNUAL 18
Net Profit8244012.2
Gross Profit 1285.6 6214.8
Operating Profit 1331.16414.9
Net Sales 8449.233071.2
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
 6515.20 (1.59%)
M.Cap (Rs. in Cr)15004.91
Dr. Reddys Lab (BSE)
 2607.20 (2.15%)
M.Cap (Rs. in Cr)43287.31
Torrent Pharma (BSE)
 1727.95 (2.76%)
M.Cap (Rs. in Cr)29240.84
Biocon (BSE)
 702.25 (5.56%)
M.Cap (Rs. in Cr)42135.00
Aurobindo Pharma (BSE)
 760.35 (4.09%)
M.Cap (Rs. in Cr)44549.49
Shareholding Pattern
PROMOTERS 74.99%
NON-INSTITUTION 15.72%
MUTUAL FUNDS/UTI 5.1%
FI/BANKS/INSURANCE 0.69%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.